Source: European Science Foundation
Date: February 19, 2007
Summary:
There is an urgent reason to study stem cells: stem cells are at the heart of some, if not all, cancers. Mounting evidence implicates a clutch of rogue stem cells brandishing ‘epigenetic’ marks as the main culprits in cancer. Wiping out tumours for good, some biologists believe, depends on uprooting these wayward stem cells.
Showing posts with label stem cell. Show all posts
Showing posts with label stem cell. Show all posts
Tuesday, February 20, 2007
Tuesday, January 23, 2007
New drug therapy to combat GVHD in stem-cell patients shows significant reduction in deaths
Source: Fred Hutchinson Cancer Research Center
Date: January 23, 2006
Summary:
Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. Now, new research from Fred Hutchinson Cancer Research Center shows that adding a widely used topical corticosteroid to the standard treatment for GVHD kept the disease in remission and significantly reduces deaths one year after therapy.
Date: January 23, 2006
Summary:
Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. Now, new research from Fred Hutchinson Cancer Research Center shows that adding a widely used topical corticosteroid to the standard treatment for GVHD kept the disease in remission and significantly reduces deaths one year after therapy.
Thursday, January 18, 2007
Stem cell test can predict risk of disease recurring
Source: Inside Bay Area
Posted: January 18, 2007 03:01:16 AM PST
Summary:
A study published in the New England Journal of Medicine found that a test using 186 genes from cancer stem cells can predict the risk of recurrence in patients with breast cancer, researchers at Stanford University School of Medicine reported. The same genes also predicted the recurrence of prostate and lung cancer and medulloblastoma, the most common form of childhood brain cancer.
Posted: January 18, 2007 03:01:16 AM PST
Summary:
A study published in the New England Journal of Medicine found that a test using 186 genes from cancer stem cells can predict the risk of recurrence in patients with breast cancer, researchers at Stanford University School of Medicine reported. The same genes also predicted the recurrence of prostate and lung cancer and medulloblastoma, the most common form of childhood brain cancer.
Sunday, January 07, 2007
Cell might sub for embryonic stem cells
Source: United Press International
Date: January 7, 2006
Summary:
Researchers say a cell found in amniotic fluid of pregnant women has many of the same traits as embryonic stem cells, the Washington Post reported. The cells are able to grow into brain, muscle and other tissues that could be used to treat diseases, researchers said, and are easily retrieved during routine prenatal testing.
Date: January 7, 2006
Summary:
Researchers say a cell found in amniotic fluid of pregnant women has many of the same traits as embryonic stem cells, the Washington Post reported. The cells are able to grow into brain, muscle and other tissues that could be used to treat diseases, researchers said, and are easily retrieved during routine prenatal testing.
Stem cell breakthrough that could end the storm
Source: Daily Mail
Date: 7 January 2007
Summary:
Scientists have shown for the first time that amniotic fluid is a rich source of stem cells, suggesting the powerful cells can be ethically harvested. They found that human stem cells, shed by the unborn baby into the surrounding amniotic fluid, can be coaxed into turning into muscle, bone, fat, blood vessel, nerve and liver cells in the lab. When the nerve cells were transplanted into mice with a degenerative brain disease, they grew and repopulated the diseased areas. Bone and liver cells also functioned well, the journal Nature Biotechnology reports. In addition to being easily obtainable, the cells can be grown quickly in large quantities.
Date: 7 January 2007
Summary:
Scientists have shown for the first time that amniotic fluid is a rich source of stem cells, suggesting the powerful cells can be ethically harvested. They found that human stem cells, shed by the unborn baby into the surrounding amniotic fluid, can be coaxed into turning into muscle, bone, fat, blood vessel, nerve and liver cells in the lab. When the nerve cells were transplanted into mice with a degenerative brain disease, they grew and repopulated the diseased areas. Bone and liver cells also functioned well, the journal Nature Biotechnology reports. In addition to being easily obtainable, the cells can be grown quickly in large quantities.
New Source of Stem Cells: Amniotic Fluid
Source: Scientific American
Date: January 7, 2007
Summary:
Scientists at the Wake Forest University School of Medicine and Harvard School of Medicine report they have isolated stem cells from a new source: amniotic fluid. The researchers not only succeeded in separating the progenitor cells from the many cells residing in the watery fluid in the placenta surrounding an embryo, but were also able to coax the cells to differentiate into muscle, bone, fat, blood vessel, liver and nerve cells.
Date: January 7, 2007
Summary:
Scientists at the Wake Forest University School of Medicine and Harvard School of Medicine report they have isolated stem cells from a new source: amniotic fluid. The researchers not only succeeded in separating the progenitor cells from the many cells residing in the watery fluid in the placenta surrounding an embryo, but were also able to coax the cells to differentiate into muscle, bone, fat, blood vessel, liver and nerve cells.
Subscribe to:
Posts (Atom)